Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy

Dermatol Ther. 2016 Sep;29(5):306-308. doi: 10.1111/dth.12380. Epub 2016 Jun 30.

Authors

L Martínez Leboráns¹, A Esteve Martínez², A M Victoria Martínez², V Alegre de Miquel², A Berrocal Jaime³

Affiliations

¹ Departments of Dermatology. lorenamarleb@gmail.com.
² Departments of Dermatology.
³ Oncology, Valencia University General Hospital, Valencia, Spain.

PMID: 27357143
DOI: 10.1111/dth.12380

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antineoplastic Agents / adverse effects*
Biopsy
Choroid Neoplasms / drug therapy*
Choroid Neoplasms / immunology
Choroid Neoplasms / pathology
Clobetasol / therapeutic use
Female
Glucocorticoids / therapeutic use
Humans
Ipilimumab
Melanoma / drug therapy*
Melanoma / immunology
Melanoma / secondary
Middle Aged
Sarcoidosis / chemically induced*
Sarcoidosis / diagnosis
Sarcoidosis / drug therapy
Skin / drug effects*
Skin / pathology
Skin Diseases / chemically induced*
Skin Diseases / diagnosis
Skin Diseases / drug therapy
Treatment Outcome

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Glucocorticoids
Ipilimumab
Clobetasol